GL Pharm Tech Corp
204840
Company Profile
Business description
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. The company possesses platform formulation technology for drug sustained release, solubilization, stabilization, and enhanced absorption in the colon.
Contact
46 Dalraenae-ro
Seongnam Global Convergence Center B-210
Gyeonggi-do
Sujeong-gu
Seongnam462713
KORT: +82 317395220
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
34
Stocks News & Analysis
stocks
Are declining Chinese births a red flag for A2 Milk?
Demographic challenges in A2’s largest market lead to sell-off.
stocks
Is this ASX share a value trap or bargain?
Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,109.10 | 16.70 | 0.18% |
| CAC 40 | 8,062.58 | 49.44 | -0.61% |
| DAX 40 | 24,703.12 | 255.94 | -1.03% |
| Dow JONES (US) | 48,488.59 | 870.74 | -1.76% |
| FTSE 100 | 10,126.78 | 68.57 | -0.67% |
| HKSE | 26,445.47 | 42.04 | -0.16% |
| NASDAQ | 22,954.32 | 561.07 | -2.39% |
| Nikkei 225 | 52,806.70 | 184.40 | -0.35% |
| NZX 50 Index | 13,418.76 | 155.17 | -1.14% |
| S&P 500 | 6,796.86 | 143.15 | -2.06% |
| S&P/ASX 200 | 8,788.60 | 19.70 | 0.22% |
| SSE Composite Index | 4,116.65 | 3.00 | 0.07% |